Seeking Alpha

Sanofi mulls the sale of certain drugs

  • Reuters reports that the French pharmaceutical firm (SNY) is working with Evercore partners to find a buyer for a portfolio of mature drugs that include treatments for high blood pressure and cardio-metabolic diseases.
  • The businesses, which generate ~$3.7B in annual sales, should fetch between $7B and $8B.
  • Generic firms or specialty pharma companies are likely acquirers.
  • Sanofi's initiative is consistent with other members of big pharma who want to shed smaller, less profitable and/or non-core businesses in order to focus on their principal growth drivers.
  • (JNJ) (MRK) (PFE) (GSK) (LLY) (NVS) (AZN)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: